- Home
- EVTL vs GOSS Comparison
EVTL vs GOSS Comparison
Compare EVTL & GOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVTL
- GOSS
- Stock Information
- Founded
- EVTL 2016
- GOSS 2015
- Country
- EVTL United Kingdom
- GOSS United States
- Employees
- EVTL N/A
- GOSS N/A
- Industry
- EVTL Aerospace
- GOSS Biotechnology: Pharmaceutical Preparations
- Sector
- EVTL Industrials
- GOSS Health Care
- Exchange
- EVTL Nasdaq
- GOSS Nasdaq
- Market Cap
- EVTL 542.9M
- GOSS 501.2M
- IPO Year
- EVTL N/A
- GOSS 2019
- Fundamental
- Price
- EVTL $4.32
- GOSS $2.36
- Analyst Decision
- EVTL Strong Buy
- GOSS Strong Buy
- Analyst Count
- EVTL 8
- GOSS 6
- Target Price
- EVTL $11.43
- GOSS $8.60
- AVG Volume (30 Days)
- EVTL 1.7M
- GOSS 3.0M
- Earning Date
- EVTL 08-05-2025
- GOSS 11-05-2025
- Dividend Yield
- EVTL N/A
- GOSS N/A
- EPS Growth
- EVTL N/A
- GOSS N/A
- EPS
- EVTL N/A
- GOSS N/A
- Revenue
- EVTL N/A
- GOSS $40,237,000.00
- Revenue This Year
- EVTL N/A
- GOSS N/A
- Revenue Next Year
- EVTL N/A
- GOSS $16.11
- P/E Ratio
- EVTL N/A
- GOSS N/A
- Revenue Growth
- EVTL N/A
- GOSS N/A
- 52 Week Low
- EVTL $2.76
- GOSS $0.66
- 52 Week High
- EVTL $15.99
- GOSS $3.60
- Technical
- Relative Strength Index (RSI)
- EVTL 38.50
- GOSS 47.88
- Support Level
- EVTL $4.13
- GOSS $2.20
- Resistance Level
- EVTL $4.68
- GOSS $2.52
- Average True Range (ATR)
- EVTL 0.27
- GOSS 0.15
- MACD
- EVTL -0.03
- GOSS 0.02
- Stochastic Oscillator
- EVTL 20.55
- GOSS 61.63
About EVTL Vertical Aerospace Ltd.
Vertical Aerospace Ltd is engaged in making air travel personal, on-demand, and carbon-free. The company is a world-wide aerospace and technology company that is pioneering electric aviation, focused on designing, manufacturing, and selling a zero operating emission eVTOL aircraft for use in the AAM market, using the technology from the aerospace, automotive, and energy industries. The VX4, Vertical's flagship aircraft, is a piloted electric vertical take-off and landing (eVTOL) vehicle capable of carrying four passengers. The Group operates as a single operating segment and one reporting segment, being the development and commercialization of eVTOL technology.
About GOSS Gossamer Bio Inc.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.